Uncategorised - European Medical Journal

Does Retreating Multiple Myeloma with Previously Refractory Drugs Work?

Patients with late line relapsed/refractory multiple myeloma (RRMM) could benefit from repeat treatment with drugs their disease has previously been refractory to.

GLP-1 Agonists May Help Reduce Alcohol-Related Hospitalisations

Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related hospitalisations.

Patrick Oliver, Alfasigma

Alfasigma’s Patrick Oliver on the company’s new chapter in the UK

Patrick Oliver, General Manager for the UK and Ireland at Alfasigma explores the company’s exciting entry into the UK market and the evolving healthcare landscape in the country.

Low-Dose IL-2 Shows Promise for Allergic Rhinitis Relief

In the trial, patients received either IL-2 (1 MUI/day) or a placebo for 5 days, followed by weekly doses for 4 weeks.

CRISPR Study Reveals Novel Rheumatoid Arthritis Targets: ACR24

Novel molecular regulators of rheumatoid arthritis (RA) inflammation were presented as part of a plenary abstract session at the ACR Convergence 2024 in Washington, D.C.

Nipocalimab In Phase II Sjögren’s Disease Trial Results: ACR24

Data from the DAHLIAS Phase II was presented at ACR Convergence 2024 in Washington, D.C., as part of an abstract plenary session, sharing efficacy and safety of nipocalimab in treating primary Sjögren’s disease.

CAR T-Cell Therapy in Solid Tumors: Latest Developments

CAR T-cell therapy, a major advancement in treating hematologic cancers, has struggled to show consistent success in solid tumors.

Neutrophil Extracellular Traps Imbalance Linked to Portal Vein Thrombosis

This study assessed neutrophil extracellular traps and DNase activity in patients with chronic hepatitis B-related decompensated cirrhosis to determine their relationship with PVT.

Racial Disparities in Pregnancy-Related Cardiovascular Mortality

New analysis finds most pregnancy-related cardiovascular deaths preventable, highlighting racial disparities and offering prevention recommendations to improve maternal health.

Revisto raises $4m to streamline pharma compliance with AI

Revisto has raised $4m in seed funding to simplify the pharmaceutical industry’s marketing compliance processes using AI.